Zoetis Inc.

ZTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $2.47B $2.26B $2.40B $2.40B $2.47B $2.20B $2.32B $2.39B
Cost of Revenue $673.0M $641.0M $701.0M $683.0M $664.0M $618.0M $707.0M $701.0M
Gross Profit $1.80B $1.62B $1.69B $1.72B $1.81B $1.58B $1.61B $1.69B
Gross Margin 72.7% 71.7% 70.7% 71.5% 73.2% 71.9% 69.5% 70.6%
Operating Expenses
Research & Development
SG&A Expense $592.0M $588.0M $611.0M $579.0M $614.0M $574.0M $625.0M $565.0M
Operating Income $927.0M $820.0M $845.0M $945.0M $965.0M $827.0M $783.0M $931.0M
Operating Margin 37.6% 36.3% 35.3% 39.4% 39.0% 37.6% 33.8% 39.0%
Interest Expense $61.0M $62.0M $57.0M $58.0M $53.0M $54.0M $51.0M $57.0M
Pretax Income $866.0M $758.0M $788.0M $887.0M $912.0M $773.0M $732.0M $874.0M
Income Tax Expense $175.0M $157.0M $164.0M $166.0M $186.0M $171.0M $151.0M $182.0M
Net Income $691.0M $601.0M $624.0M $721.0M $726.0M $602.0M $581.0M $682.0M
Net Margin 28.0% 26.6% 26.1% 30.0% 29.3% 27.4% 25.1% 28.6%
EPS (Basic) $1.65 $1.42 $1.43 $1.63 $1.63 $1.34 $1.28 $1.51
EPS (Diluted) $1.65 $1.42 $1.42 $1.63 $1.63 $1.34 $1.29 $1.50
Shares Outstanding (Basic) 417.6M 422.1M 443.4M 442.9M 445.1M 447.6M 454.2M 452.9M
Shares Outstanding (Diluted) 417.7M 422.4M 443.8M 443.2M 445.5M 448.0M 454.8M 453.5M
Dividends Per Share $0.53 $0.53 $1.03 $0.00 $0.50 $0.50 $0.93 $0.00
← Newer Page 1 of 8 Older →